nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Infusion related reaction—Capecitabine—colon cancer	0.0724	0.0724	CcSEcCtD
Verteporfin—Peripheral vascular disorder—Irinotecan—colon cancer	0.0208	0.0208	CcSEcCtD
Verteporfin—Varicose vein—Capecitabine—colon cancer	0.0183	0.0183	CcSEcCtD
Verteporfin—Sunburn—Methotrexate—colon cancer	0.0168	0.0168	CcSEcCtD
Verteporfin—Blepharitis—Fluorouracil—colon cancer	0.0159	0.0159	CcSEcCtD
Verteporfin—Blister—Fluorouracil—colon cancer	0.0135	0.0135	CcSEcCtD
Verteporfin—Extravasation—Vincristine—colon cancer	0.012	0.012	CcSEcCtD
Verteporfin—Extravasation—Irinotecan—colon cancer	0.0117	0.0117	CcSEcCtD
Verteporfin—Visual acuity reduced—Capecitabine—colon cancer	0.0115	0.0115	CcSEcCtD
Verteporfin—Extravasation—Fluorouracil—colon cancer	0.0112	0.0112	CcSEcCtD
Verteporfin—Raised liver function tests—Methotrexate—colon cancer	0.011	0.011	CcSEcCtD
Verteporfin—Musculoskeletal pain—Vincristine—colon cancer	0.0106	0.0106	CcSEcCtD
Verteporfin—Inflammation—Fluorouracil—colon cancer	0.0101	0.0101	CcSEcCtD
Verteporfin—Blister—Capecitabine—colon cancer	0.00947	0.00947	CcSEcCtD
Verteporfin—Hyperaesthesia—Capecitabine—colon cancer	0.00869	0.00869	CcSEcCtD
Verteporfin—Injection site pain—Capecitabine—colon cancer	0.00836	0.00836	CcSEcCtD
Verteporfin—Photosensitivity—Fluorouracil—colon cancer	0.00807	0.00807	CcSEcCtD
Verteporfin—Visual disturbance—Irinotecan—colon cancer	0.00781	0.00781	CcSEcCtD
Verteporfin—Dermatitis bullous—Fluorouracil—colon cancer	0.00742	0.00742	CcSEcCtD
Verteporfin—Osteoarthritis—Irinotecan—colon cancer	0.0074	0.0074	CcSEcCtD
Verteporfin—Hearing impaired—Capecitabine—colon cancer	0.00717	0.00717	CcSEcCtD
Verteporfin—Cataract—Capecitabine—colon cancer	0.00717	0.00717	CcSEcCtD
Verteporfin—Osteoarthritis—Fluorouracil—colon cancer	0.00709	0.00709	CcSEcCtD
Verteporfin—Inflammation—Capecitabine—colon cancer	0.00704	0.00704	CcSEcCtD
Verteporfin—Blood creatinine increased—Irinotecan—colon cancer	0.00693	0.00693	CcSEcCtD
Verteporfin—Injection site reaction—Capecitabine—colon cancer	0.00678	0.00678	CcSEcCtD
Verteporfin—Muscular weakness—Vincristine—colon cancer	0.0067	0.0067	CcSEcCtD
Verteporfin—Dry eye—Capecitabine—colon cancer	0.0063	0.0063	CcSEcCtD
Verteporfin—Muscular weakness—Fluorouracil—colon cancer	0.00625	0.00625	CcSEcCtD
Verteporfin—Photosensitivity reaction—Vincristine—colon cancer	0.006	0.006	CcSEcCtD
Verteporfin—Pneumonia—Vincristine—colon cancer	0.00589	0.00589	CcSEcCtD
Verteporfin—Extravasation—Methotrexate—colon cancer	0.00582	0.00582	CcSEcCtD
Verteporfin—Acute coronary syndrome—Vincristine—colon cancer	0.00577	0.00577	CcSEcCtD
Verteporfin—Myocardial infarction—Vincristine—colon cancer	0.00574	0.00574	CcSEcCtD
Verteporfin—Pneumonia—Irinotecan—colon cancer	0.00574	0.00574	CcSEcCtD
Verteporfin—Sleep disorder—Capecitabine—colon cancer	0.00572	0.00572	CcSEcCtD
Verteporfin—Photosensitivity—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Verteporfin—Acute coronary syndrome—Irinotecan—colon cancer	0.00562	0.00562	CcSEcCtD
Verteporfin—Sweating—Vincristine—colon cancer	0.00562	0.00562	CcSEcCtD
Verteporfin—Photosensitivity reaction—Fluorouracil—colon cancer	0.00559	0.00559	CcSEcCtD
Verteporfin—Myocardial infarction—Irinotecan—colon cancer	0.00559	0.00559	CcSEcCtD
Verteporfin—Pneumonia—Fluorouracil—colon cancer	0.00549	0.00549	CcSEcCtD
Verteporfin—Sweating—Irinotecan—colon cancer	0.00547	0.00547	CcSEcCtD
Verteporfin—Acute coronary syndrome—Fluorouracil—colon cancer	0.00539	0.00539	CcSEcCtD
Verteporfin—Myocardial infarction—Fluorouracil—colon cancer	0.00536	0.00536	CcSEcCtD
Verteporfin—Conjunctivitis—Fluorouracil—colon cancer	0.00531	0.00531	CcSEcCtD
Verteporfin—Inflammation—Methotrexate—colon cancer	0.00524	0.00524	CcSEcCtD
Verteporfin—Hypoaesthesia—Vincristine—colon cancer	0.00523	0.00523	CcSEcCtD
Verteporfin—Atrial fibrillation—Capecitabine—colon cancer	0.00523	0.00523	CcSEcCtD
Verteporfin—Dermatitis bullous—Capecitabine—colon cancer	0.00518	0.00518	CcSEcCtD
Verteporfin—Haemoglobin—Irinotecan—colon cancer	0.00515	0.00515	CcSEcCtD
Verteporfin—Haemorrhage—Irinotecan—colon cancer	0.00512	0.00512	CcSEcCtD
Verteporfin—Diplopia—Capecitabine—colon cancer	0.00495	0.00495	CcSEcCtD
Verteporfin—Osteoarthritis—Capecitabine—colon cancer	0.00495	0.00495	CcSEcCtD
Verteporfin—Visual impairment—Irinotecan—colon cancer	0.00493	0.00493	CcSEcCtD
Verteporfin—Haemoglobin—Fluorouracil—colon cancer	0.00493	0.00493	CcSEcCtD
Verteporfin—Haemorrhage—Fluorouracil—colon cancer	0.0049	0.0049	CcSEcCtD
Verteporfin—Cardiac disorder—Vincristine—colon cancer	0.00488	0.00488	CcSEcCtD
Verteporfin—Hypoaesthesia—Fluorouracil—colon cancer	0.00488	0.00488	CcSEcCtD
Verteporfin—Pharyngitis—Fluorouracil—colon cancer	0.00487	0.00487	CcSEcCtD
Verteporfin—Angiopathy—Vincristine—colon cancer	0.00477	0.00477	CcSEcCtD
Verteporfin—Cardiac disorder—Irinotecan—colon cancer	0.00475	0.00475	CcSEcCtD
Verteporfin—Flushing—Irinotecan—colon cancer	0.00475	0.00475	CcSEcCtD
Verteporfin—Angiopathy—Irinotecan—colon cancer	0.00465	0.00465	CcSEcCtD
Verteporfin—Blood creatinine increased—Capecitabine—colon cancer	0.00464	0.00464	CcSEcCtD
Verteporfin—Immune system disorder—Irinotecan—colon cancer	0.00463	0.00463	CcSEcCtD
Verteporfin—Liver function test abnormal—Capecitabine—colon cancer	0.00457	0.00457	CcSEcCtD
Verteporfin—Back pain—Vincristine—colon cancer	0.00443	0.00443	CcSEcCtD
Verteporfin—Muscular weakness—Capecitabine—colon cancer	0.00437	0.00437	CcSEcCtD
Verteporfin—Back pain—Irinotecan—colon cancer	0.00431	0.00431	CcSEcCtD
Verteporfin—Influenza—Capecitabine—colon cancer	0.00428	0.00428	CcSEcCtD
Verteporfin—Anaemia—Vincristine—colon cancer	0.00423	0.00423	CcSEcCtD
Verteporfin—Photosensitivity—Methotrexate—colon cancer	0.0042	0.0042	CcSEcCtD
Verteporfin—Ill-defined disorder—Irinotecan—colon cancer	0.00414	0.00414	CcSEcCtD
Verteporfin—Anaemia—Irinotecan—colon cancer	0.00412	0.00412	CcSEcCtD
Verteporfin—Vertigo—Vincristine—colon cancer	0.00411	0.00411	CcSEcCtD
Verteporfin—Vision blurred—Fluorouracil—colon cancer	0.00402	0.00402	CcSEcCtD
Verteporfin—Malaise—Irinotecan—colon cancer	0.00402	0.00402	CcSEcCtD
Verteporfin—Vertigo—Irinotecan—colon cancer	0.004	0.004	CcSEcCtD
Verteporfin—Syncope—Irinotecan—colon cancer	0.004	0.004	CcSEcCtD
Verteporfin—Hypertension—Vincristine—colon cancer	0.00395	0.00395	CcSEcCtD
Verteporfin—Anaemia—Fluorouracil—colon cancer	0.00395	0.00395	CcSEcCtD
Verteporfin—Loss of consciousness—Irinotecan—colon cancer	0.00392	0.00392	CcSEcCtD
Verteporfin—Photosensitivity reaction—Capecitabine—colon cancer	0.00391	0.00391	CcSEcCtD
Verteporfin—Visual disturbance—Methotrexate—colon cancer	0.00389	0.00389	CcSEcCtD
Verteporfin—Cough—Irinotecan—colon cancer	0.00389	0.00389	CcSEcCtD
Verteporfin—Hypertension—Irinotecan—colon cancer	0.00385	0.00385	CcSEcCtD
Verteporfin—Pneumonia—Capecitabine—colon cancer	0.00384	0.00384	CcSEcCtD
Verteporfin—Acute coronary syndrome—Capecitabine—colon cancer	0.00376	0.00376	CcSEcCtD
Verteporfin—Discomfort—Irinotecan—colon cancer	0.00375	0.00375	CcSEcCtD
Verteporfin—Myocardial infarction—Capecitabine—colon cancer	0.00374	0.00374	CcSEcCtD
Verteporfin—Oedema—Vincristine—colon cancer	0.00374	0.00374	CcSEcCtD
Verteporfin—Conjunctivitis—Capecitabine—colon cancer	0.00371	0.00371	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—colon cancer	0.00369	0.00369	CcSEcCtD
Verteporfin—Nervous system disorder—Vincristine—colon cancer	0.00366	0.00366	CcSEcCtD
Verteporfin—Oedema—Irinotecan—colon cancer	0.00364	0.00364	CcSEcCtD
Verteporfin—Chest pain—Fluorouracil—colon cancer	0.00363	0.00363	CcSEcCtD
Verteporfin—Hyperhidrosis—Vincristine—colon cancer	0.00361	0.00361	CcSEcCtD
Verteporfin—Discomfort—Fluorouracil—colon cancer	0.00359	0.00359	CcSEcCtD
Verteporfin—Shock—Irinotecan—colon cancer	0.00358	0.00358	CcSEcCtD
Verteporfin—Nervous system disorder—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Verteporfin—Hyperhidrosis—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Verteporfin—Oedema—Fluorouracil—colon cancer	0.00348	0.00348	CcSEcCtD
Verteporfin—Haemoglobin—Capecitabine—colon cancer	0.00344	0.00344	CcSEcCtD
Verteporfin—Haemorrhage—Capecitabine—colon cancer	0.00343	0.00343	CcSEcCtD
Verteporfin—Nervous system disorder—Fluorouracil—colon cancer	0.00342	0.00342	CcSEcCtD
Verteporfin—Hypoaesthesia—Capecitabine—colon cancer	0.00341	0.00341	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—colon cancer	0.0034	0.0034	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Vincristine—colon cancer	0.0034	0.0034	CcSEcCtD
Verteporfin—Pharyngitis—Capecitabine—colon cancer	0.0034	0.0034	CcSEcCtD
Verteporfin—Visual impairment—Capecitabine—colon cancer	0.0033	0.0033	CcSEcCtD
Verteporfin—Dyspnoea—Irinotecan—colon cancer	0.00324	0.00324	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Vincristine—colon cancer	0.00322	0.00322	CcSEcCtD
Verteporfin—Eye disorder—Capecitabine—colon cancer	0.0032	0.0032	CcSEcCtD
Verteporfin—Pain—Vincristine—colon cancer	0.00319	0.00319	CcSEcCtD
Verteporfin—Constipation—Vincristine—colon cancer	0.00319	0.00319	CcSEcCtD
Verteporfin—Cardiac disorder—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Verteporfin—Flushing—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00317	0.00317	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00314	0.00314	CcSEcCtD
Verteporfin—Pain—Irinotecan—colon cancer	0.00311	0.00311	CcSEcCtD
Verteporfin—Constipation—Irinotecan—colon cancer	0.00311	0.00311	CcSEcCtD
Verteporfin—Angiopathy—Capecitabine—colon cancer	0.00311	0.00311	CcSEcCtD
Verteporfin—Dyspnoea—Fluorouracil—colon cancer	0.00311	0.00311	CcSEcCtD
Verteporfin—Immune system disorder—Capecitabine—colon cancer	0.0031	0.0031	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00301	0.00301	CcSEcCtD
Verteporfin—Feeling abnormal—Irinotecan—colon cancer	0.003	0.003	CcSEcCtD
Verteporfin—Malnutrition—Capecitabine—colon cancer	0.00298	0.00298	CcSEcCtD
Verteporfin—Pain—Fluorouracil—colon cancer	0.00298	0.00298	CcSEcCtD
Verteporfin—Body temperature increased—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—colon cancer	0.00291	0.00291	CcSEcCtD
Verteporfin—Back pain—Capecitabine—colon cancer	0.00289	0.00289	CcSEcCtD
Verteporfin—Body temperature increased—Irinotecan—colon cancer	0.00288	0.00288	CcSEcCtD
Verteporfin—Feeling abnormal—Fluorouracil—colon cancer	0.00287	0.00287	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—colon cancer	0.00286	0.00286	CcSEcCtD
Verteporfin—Vision blurred—Capecitabine—colon cancer	0.00281	0.00281	CcSEcCtD
Verteporfin—Ill-defined disorder—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Verteporfin—Urticaria—Fluorouracil—colon cancer	0.00277	0.00277	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—colon cancer	0.00276	0.00276	CcSEcCtD
Verteporfin—Anaemia—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Verteporfin—Body temperature increased—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Verteporfin—Hypersensitivity—Vincristine—colon cancer	0.00275	0.00275	CcSEcCtD
Verteporfin—Sweating—Methotrexate—colon cancer	0.00272	0.00272	CcSEcCtD
Verteporfin—Malaise—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Verteporfin—Vertigo—Capecitabine—colon cancer	0.00268	0.00268	CcSEcCtD
Verteporfin—Hypersensitivity—Irinotecan—colon cancer	0.00268	0.00268	CcSEcCtD
Verteporfin—Asthenia—Vincristine—colon cancer	0.00268	0.00268	CcSEcCtD
Verteporfin—Syncope—Capecitabine—colon cancer	0.00268	0.00268	CcSEcCtD
Verteporfin—Loss of consciousness—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Verteporfin—Asthenia—Irinotecan—colon cancer	0.00261	0.00261	CcSEcCtD
Verteporfin—Cough—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Verteporfin—Hypertension—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Verteporfin—Hypersensitivity—Fluorouracil—colon cancer	0.00257	0.00257	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—colon cancer	0.00256	0.00256	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Verteporfin—Arthralgia—Capecitabine—colon cancer	0.00254	0.00254	CcSEcCtD
Verteporfin—Chest pain—Capecitabine—colon cancer	0.00254	0.00254	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00252	0.00252	CcSEcCtD
Verteporfin—Discomfort—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Verteporfin—Dizziness—Vincristine—colon cancer	0.00247	0.00247	CcSEcCtD
Verteporfin—Pruritus—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—colon cancer	0.00246	0.00246	CcSEcCtD
Verteporfin—Oedema—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Verteporfin—Dizziness—Irinotecan—colon cancer	0.00241	0.00241	CcSEcCtD
Verteporfin—Shock—Capecitabine—colon cancer	0.0024	0.0024	CcSEcCtD
Verteporfin—Nervous system disorder—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—colon cancer	0.00238	0.00238	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Verteporfin—Skin disorder—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Verteporfin—Rash—Vincristine—colon cancer	0.00236	0.00236	CcSEcCtD
Verteporfin—Hyperhidrosis—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Dermatitis—Vincristine—colon cancer	0.00235	0.00235	CcSEcCtD
Verteporfin—Headache—Vincristine—colon cancer	0.00234	0.00234	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—colon cancer	0.00231	0.00231	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—colon cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Dizziness—Fluorouracil—colon cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Rash—Irinotecan—colon cancer	0.00229	0.00229	CcSEcCtD
Verteporfin—Dermatitis—Irinotecan—colon cancer	0.00229	0.00229	CcSEcCtD
Verteporfin—Headache—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—colon cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Nausea—Vincristine—colon cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Rash—Fluorouracil—colon cancer	0.0022	0.0022	CcSEcCtD
Verteporfin—Dermatitis—Fluorouracil—colon cancer	0.00219	0.00219	CcSEcCtD
Verteporfin—Headache—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Verteporfin—Dyspnoea—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Verteporfin—Nausea—Irinotecan—colon cancer	0.00216	0.00216	CcSEcCtD
Verteporfin—Back pain—Methotrexate—colon cancer	0.00215	0.00215	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—colon cancer	0.00209	0.00209	CcSEcCtD
Verteporfin—Pain—Capecitabine—colon cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Constipation—Capecitabine—colon cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Nausea—Fluorouracil—colon cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Verteporfin—Feeling abnormal—Capecitabine—colon cancer	0.00201	0.00201	CcSEcCtD
Verteporfin—Malaise—Methotrexate—colon cancer	0.002	0.002	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—colon cancer	0.002	0.002	CcSEcCtD
Verteporfin—Cough—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Urticaria—Capecitabine—colon cancer	0.00193	0.00193	CcSEcCtD
Verteporfin—Body temperature increased—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—colon cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—colon cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Hypersensitivity—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—colon cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Asthenia—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Pruritus—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Dizziness—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Verteporfin—Pain—Methotrexate—colon cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Rash—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Dermatitis—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Headache—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Nausea—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Rash—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Headache—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Nausea—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
